• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Amgen

heart
Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism

Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol

by Julia Mardi February 27, 2024April 19, 2024

The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.

Posted inClinical Trials, Metabolism

Dorzagliatin: Drug That Can “Cure” Diabetes

by Julia Mardi and Timur Burkhanayev November 13, 2022November 13, 2022

Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.

multiple-myeloma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Tecvayli: New Drug for Multiple Myeloma

by Mark Gubar August 24, 2022September 8, 2022

Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.

psoriasis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zoryve: New Effective Cream for Psoriasis

by Tanya von Reuss and Julia Mardi August 1, 2022September 8, 2022

Roflumilast will cure plaque psoriasis in half of patients.

asthma
Posted inAutoimmune Diseases, New Drugs, Regulatory

Tezspire: Effective Treatment for Severe Uncontrolled Asthma

by Mark Gubar December 19, 2021September 8, 2022

Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.

Posted inClinical Trials, Oncology

Bemarituzumab: Breakthrough in Gastric Cancer Treatment

by Julia Mardi and Alex Avisoni April 7, 2021September 8, 2022

A new and effective targeted therapy, being developed by Five Prime Therapeutics and Amgen, for a deadly cancer disease in the past decade.

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

by Tanya von Reuss and Timur Burkhanayev April 3, 2021September 8, 2022

A deadly disease and modern pharmacological attempts to treat it.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×